Comparative Pharmacology
Head-to-head clinical analysis: CYSTEINE HYDROCHLORIDE versus MUCOSIL 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYSTEINE HYDROCHLORIDE versus MUCOSIL 10.
CYSTEINE HYDROCHLORIDE vs MUCOSIL-10
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cysteine hydrochloride serves as a precursor to glutathione, an important antioxidant. It also provides a source of cysteine for protein synthesis and acts as a mucolytic agent by reducing disulfide bonds in mucus glycoproteins, thereby decreasing viscosity.
MUCOSIL-10 is a mucolytic agent containing N-acetylcysteine. It reduces mucus viscosity by cleaving disulfide bonds in mucoproteins via free sulfhydryl groups, thereby facilitating expectoration. It also exhibits antioxidant properties by replenishing glutathione stores and neutralizing reactive oxygen species.
Intravenous: 0.8-1 g/m²/day divided every 6 hours for acetaminophen poisoning; for parenteral nutrition, 0.66-1.7 g of cysteine/kg/day (as hydrochloride).
10 mg orally once daily
None Documented
None Documented
Terminal elimination half-life: 1.5-3 hours in adults with normal renal function; prolonged in renal impairment (up to 8-10 hours in severe cases).
Terminal elimination half-life is approximately 3-4 hours in adults with normal renal function; may be prolonged to 6-8 hours in patients with moderate renal impairment (CrCl <50 mL/min).
Renal: 40-60% as unchanged drug and metabolites; fecal: <5%; minor biliary elimination; route of administration (e.g., intravenous) influences exact percentages.
Primarily renal elimination with 60-70% of the dose excreted unchanged in urine; biliary/fecal excretion accounts for 10-15% as metabolites, with the remainder via other pathways.
Category C
Category C
Mucolytic
Mucolytic